Manufacturing

Articles

Avid Bioservices is building a viral vector development and manufacturing facility near its existing biologics manufacturing facility in California. 

Avid Bioservices Expands into Viral Vector Development and Manufacturing Services

Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.

Thermo Fisher Scientific Opens Biologics Manufacturing Site in Lengnau, Switzerland

Feliza Mirasol is the science editor for 

The complexity of newer biotherapeutic molecules calls for alternative drug delivery strategies.

Next-Gen Technologies Tackle Drug Delivery Challenges

Advancements in bioprocessing technologies test microbial fermentation adaptability.

Bioprocessing Innovations Pose New Challenges for Fermentation

Avantor plans to address rising global demand for biologics with their investment in hydration capabilities.

Avantor Makes Multi-Year Investment in Hydration Capabilities for Biologics Production

AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.

AGC Biologics Breaks Ground on New Multipurpose Facility in Denmark

Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.

Lonza Invests in Drug Product Manufacturing Services in China

Syngene’s additions include a new microbial facility and an expanded mammalian facility.

Syngene Expands Microbial and Mammalian Manufacturing Facilities in Bengalaru

PNI expands global headquarters with a new 75,000-square-foot facility, which will include multiple GMP suites for manufacturing RNA therapeutics and vaccines.

Precision NanoSystems Expands GMP Biomanufacturing Center 

Rentschler Biopharma has broken ground nearby its Milford, Mass., site where it will build its new multi-product manufacturing facility for commercial production of complex molecules. 

Manufacturing, Biologics